Pfizer pflu?
Executive Summary
Pfizer CEO Hank McKinnell will reschedule his Feb. 4 speech at the National Press Club after coming down with the flu. McKinnell was slated to speak on health care reform, but was likely to have also addressed - either through prepared remarks or during the question and answer session - the cardiovascular safety questions surrounding Pfizer's COX-2 inhibitors Celebrex and Bextra (1"The Pink Sheet" Jan. 3, 2005, p. 17). Pfizer says McKinnell caught the flu while traveling through southern Asia to assess the company's tsunami relief effort...
You may also be interested in...
FDA Issues Caution On COX-2s, But Leaves Open Possibility For First-Line Use
FDA's caution on the use of COX-2 inhibitors leaves open the possibility for patients to use Pfizer's Celebrex and Bextra as first-line therapies
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.